SCHEMBL30607491

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)CN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)C(C)C

nearest known ligand 0.57

Predicted protein targets (top 11)

	gene	UniProt	supporting neighbours	confidence
▸	VIPR2	P41587	7/20	0.56

▸	VIPR1	P32241	5/20	0.55

▸	GLP1R	P43220	4/20	0.53

▸	GCGR	P47871	1/20	0.53

▸	GIPR	P48546	1/20	0.53

▸	CALCR	P30988	3/20	0.51

▸	CCKBR	P32239	1/20	0.51

▸	IL23R	Q5VWK5	2/20	0.51

▸	BACE1	P56817	1/20	0.50

▸	CRHR1	P34998	1/20	0.50

▸	CRHR2	Q13324	1/20	0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30607352	0.88	GLP1R (0.57)	VIPR2VIPR1GLP1RGCGRGIPR
SCHEMBL29438037	0.87	BACE1 (0.60)	VIPR2VIPR1GLP1RGCGRGIPR
SCHEMBL30903279	0.87	BACE1 (0.62)	VIPR2VIPR1GLP1RGCGRGIPR
SCHEMBL31182653	0.87	BACE1 (0.62)	VIPR2VIPR1BACE1
SCHEMBL30431778	0.86	GLP1R (0.59)	VIPR1GLP1RGCGRGIPRCALCR
SCHEMBL29649226	0.86	VIPR2 (0.60)	VIPR2VIPR1GLP1RCALCRCCKBR
SCHEMBL31517010	0.85	GLP1R (0.64)	VIPR2VIPR1GLP1RGCGRGIPR
SCHEMBL30168788	0.85	BACE1 (0.56)	VIPR2VIPR1GLP1RCCKBRBACE1
SCHEMBL31622476	0.84	VIPR1 (0.55)	VIPR2VIPR1GLP1RBACE1
SCHEMBL30880889	0.84	BACE1 (0.54)	VIPR2VIPR1GLP1RGCGRGIPR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-12383505-B2	Nanoparticle for the remodeling of cancer-associated fibroblasts	UNIVERSITY OF SOUTH CAROLINA (US)	2025-08-12	—	—	US	disclosed
US-20230310331-A1	NANOPARTICLE FOR THE REMODELING OF CANCER-ASSOCIATED FIBROBLASTS	UNIVERSITY OF SOUTH CAROLINA (US)	2023-10-05	—	—	US	disclosed